Table 1.
Descriptive analysis of the demographic and clinical data of cases and controls.
| Characteristics | Psoriasis patients (n = 210) | Controls (n = 111) | P value |
|---|---|---|---|
| Age (years), mean ± SD | 52.22 ± 9.85 | 52.30 ± 9.55 | P = 0.994 |
| Gender | |||
| Male, % (n) | 67.62% (142) | 67.57% (75) | P = 0.992 |
| PASI, mean | 15.44 ± 8.67 | ||
| Range | 4–46.7 | ||
| PASI < 10, % (n) | 33% (70) | ||
| PASI ≥ 10, % (n) | 77% (140) | ||
| Psoriasis type I, % (n) | 59.05% (124) | ||
| Psoriasis type II, % (n) | 40.95% (86) | ||
| CUORE project risk score, | |||
| Mean ± SD | 6.80 ± 6.34 | 4.48 ± 4.38 | P < 0.001 |
| 35–44 years | 2.32 ± 1.65 | 1.11 ± 0.74 | P < 0.001 |
| 45–54 years | 4.43 ± 3.47 | 2.53 ± 1.39 | P < 0.001 |
| 55–69 years | 12.99 ± 15.16 | 8.07 ± 4.68 | P = 0.006 |